Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to $4.2 million.

  • Jaguar Health's Accumulated Expenses rose 2663.03% to $4.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.2 million, marking a year-over-year increase of 2663.03%. This contributed to the annual value of $1.9 million for FY2024, which is 4968.4% down from last year.
  • Jaguar Health's Accumulated Expenses amounted to $4.2 million in Q3 2025, which was up 2663.03% from $3.6 million recorded in Q2 2025.
  • Over the past 5 years, Jaguar Health's Accumulated Expenses peaked at $10.0 million during Q2 2023, and registered a low of $1.9 million during Q4 2024.
  • In the last 5 years, Jaguar Health's Accumulated Expenses had a median value of $6.1 million in 2021 and averaged $5.7 million.
  • In the last 5 years, Jaguar Health's Accumulated Expenses skyrocketed by 9368.39% in 2021 and then plummeted by 6667.0% in 2024.
  • Jaguar Health's Accumulated Expenses (Quarter) stood at $7.1 million in 2021, then increased by 14.73% to $8.2 million in 2022, then plummeted by 53.48% to $3.8 million in 2023, then crashed by 49.68% to $1.9 million in 2024, then surged by 118.47% to $4.2 million in 2025.
  • Its last three reported values are $4.2 million in Q3 2025, $3.6 million for Q2 2025, and $2.1 million during Q1 2025.